Understanding about Image-guided Detection of Prostate Cancer

Abstract

The prostate is both an accessory gland of the male reproductive system and a muscle-driven mechanical switch between urination and ejaculation. Anatomically, the prostate is found below the bladder, with the urethra passing through it. Prostate cancer (PCa) is the second-most prevalent cancer and the fifth leading cause of cancer-specific mortality in male, worldwide. Currently, the only sure way to confirm prostate cancer is through a prostate biopsy. Rapid technological advances over the past few years have enabled the mainstream use of prostate imaging for the clinical management of prostate cancer. In biopsy for the diagnosis of prostate cancer, prostate imaging technology is mobilized to extract tissue from the exact area. Ultrasound imaging, MRI, and PET imaging methods are used for prostate imaging methods. Although each image has its own characteristics, the recent trend is the fusion image method that uses each other's strengths. There is currently no technology that can fully meet the clinical requirements of speed and high precision at the same time at a low cost. The development of a biopsy framework that is inexpensive, easy to use, and has minimal clinical overhead seems necessary. This requires the implementation of new image registration and visualization approaches and the establishment of a research platform for rapid bench-to-bed conversion.